The IPO has generated significant excitement in the grey market, where it is currently trading at a Grey Market Premium (GMP) ...
Kusumgar Limited has raised ₹193.9 crore from anchor investors for its IPO, allocating 4,628,877 shares at ₹419 each. The IPO ...
Peer-reviewed preclinical melanoma research finds Provectus’s synthetic small molecule can both stimulate anti-tumor immunity and suppress peripheral immune cells at the same dose.
Abstract: Oceans cover approximately 71% of the Earth's surface and provide numerous services to the environment and humans. Precise, real-time, and large-scale monitoring of the oceanographic ...
Kusumgar's Rs 650-crore IPO will open for subscription on July 8, with the issue commanding a grey market premium of around ...